137 related articles for article (PubMed ID: 3324444)
61. Expression of cellular protooncogenes in the mouse male germ line: a distinctive 2.4-kilobase pim-1 transcript is expressed in haploid postmeiotic cells.
Sorrentino V; McKinney MD; Giorgi M; Geremia R; Fleissner E
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2191-5. PubMed ID: 2965388
[TBL] [Abstract][Full Text] [Related]
62. Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line.
Huber BE; Dearfield KL; Williams JR; Heilman CA; Thorgeirsson SS
Cancer Res; 1985 Sep; 45(9):4322-9. PubMed ID: 2992777
[TBL] [Abstract][Full Text] [Related]
63. Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer.
Tsuchiya T; Ueyama Y; Tamaoki N; Yamaguchi S; Shibuya M
Jpn J Cancer Res; 1989 Oct; 80(10):920-3. PubMed ID: 2575609
[TBL] [Abstract][Full Text] [Related]
64. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
Pichon F; Seuwen K; Pouysségur J; Lagarde AE
Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
[TBL] [Abstract][Full Text] [Related]
65. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA
Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517
[TBL] [Abstract][Full Text] [Related]
66. Proto-oncogene expression in a human chondrosarcoma cell line: HCS-2/8.
Zhu JD; Pan HO; Suzuki F; Takigawa M
Jpn J Cancer Res; 1994 Apr; 85(4):364-71. PubMed ID: 8200849
[TBL] [Abstract][Full Text] [Related]
67. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.
Geiser AG; Der CJ; Marshall CJ; Stanbridge EJ
Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5209-13. PubMed ID: 3523486
[TBL] [Abstract][Full Text] [Related]
68. Heterogeneous expression of oncogenes in small-cell lung-cancer xenografts.
Arvelo F; Poupon M; Baldeyrou P; Lechevalier T
Int J Oncol; 1993 Apr; 2(4):621-5. PubMed ID: 21573601
[TBL] [Abstract][Full Text] [Related]
69. Proto-oncogene expression in chicken leukemic cells induced by avian myeloblastosis virus.
Kim WK; Baluda MA
Oncogene Res; 1988 Sep; 3(2):147-54. PubMed ID: 3226723
[TBL] [Abstract][Full Text] [Related]
70. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
71. Differential expression of protooncogenes related to transformation and cancer progression in rat myoblasts.
Leibovitch SA; Leibovitch MP; Guillier M; Hillion J; Harel J
Cancer Res; 1986 Aug; 46(8):4097-103. PubMed ID: 2425941
[TBL] [Abstract][Full Text] [Related]
72. Amplification, rearrangement, and elevated expression of c-myc in the human prostatic carcinoma cell line LNCaP.
Nag A; Smith RG
Prostate; 1989; 15(2):115-22. PubMed ID: 2678039
[TBL] [Abstract][Full Text] [Related]
73. [Proto-oncogene expression in human carcinomas of the stomach and in the gastric mucosa of rats exposed to N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis].
Novikov LB; Kalinovskiĭ VP; Kniazev PG; Fedorov SN; Tlevlesov NIa
Eksp Onkol; 1989; 11(1):18-21. PubMed ID: 2924705
[TBL] [Abstract][Full Text] [Related]
74. Cytomorphological, cytogenetic, and molecular biological characterization of four new human renal carcinoma cell lines of the clear cell type.
Gerharz CD; Ramp U; Olert J; Moll R; Störkel S; Marx N; Gabbert HE
Virchows Arch; 1994; 424(4):403-9. PubMed ID: 7515757
[TBL] [Abstract][Full Text] [Related]
75. Sequential expression of proto-oncogenes during a mouse erythroleukemia cell differentiation.
Todokoro K; Ikawa Y
Biochem Biophys Res Commun; 1986 Mar; 135(3):1112-8. PubMed ID: 3457564
[TBL] [Abstract][Full Text] [Related]
76. [Transcription of cellular oncogenes in human tumors].
Spitkovskiĭ DD; Zborovskaia IB; Kiselev FL
Mol Biol (Mosk); 1986; 20(5):1409-21. PubMed ID: 3773891
[TBL] [Abstract][Full Text] [Related]
77. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
78. Induction of v-mos and activated Ha-ras oncogene expression in quiescent NIH 3T3 cells causes intracellular alkalinisation and cell-cycle progression.
Doppler W; Jaggi R; Groner B
Gene; 1987; 54(1):147-53. PubMed ID: 3038697
[TBL] [Abstract][Full Text] [Related]
79. [Significance of oncogenes and growth factors in hypernephroma].
Peter S
Urologe A; 1992 Jan; 31(1):24-7. PubMed ID: 1553800
[TBL] [Abstract][Full Text] [Related]
80. Aberrant expression of the K-ras proto-oncogene in B-cell malignancies.
Lee J; Talpaz M; Walters R; Gutterman JU; Blick M
Hematol Pathol; 1988; 2(4):229-37. PubMed ID: 3075608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
